Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4854733
Max Phase: Preclinical
Molecular Formula: C28H38N3O5P
Molecular Weight: 527.60
Molecule Type: Unknown
Associated Items:
ID: ALA4854733
Max Phase: Preclinical
Molecular Formula: C28H38N3O5P
Molecular Weight: 527.60
Molecule Type: Unknown
Associated Items:
Canonical SMILES: COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)CP(=O)(O)[C@@H](N)CCc1ccccc1
Standard InChI: InChI=1S/C28H38N3O5P/c1-19(2)15-22(18-37(34,35)26(29)14-13-20-9-5-4-6-10-20)27(32)31-25(28(33)36-3)16-21-17-30-24-12-8-7-11-23(21)24/h4-12,17,19,22,25-26,30H,13-16,18,29H2,1-3H3,(H,31,32)(H,34,35)/t22-,25+,26-/m1/s1
Standard InChI Key: QWLYILUODIZPOK-ZSQFBXSQSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 527.60 | Molecular Weight (Monoisotopic): 527.2549 | AlogP: 4.22 | #Rotatable Bonds: 13 |
Polar Surface Area: 134.51 | Molecular Species: ZWITTERION | HBA: 5 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 8 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 0.00 | CX Basic pKa: 9.61 | CX LogP: 2.73 | CX LogD: 2.72 |
Aromatic Rings: 3 | Heavy Atoms: 37 | QED Weighted: 0.19 | Np Likeness Score: 0.16 |
1. Wilding B, Pasqua AE, E A Chessum N, Pierrat OA, Hahner T, Tomlin K, Shehu E, Burke R, Richards GM, Whitton B, Arwert EN, Thapaliya A, Salimraj R, van Montfort R, Skawinska A, Hayes A, Raynaud F, Chopra R, Jones K, Newton G, Cheeseman MD.. (2021) Investigating the phosphinic acid tripeptide mimetic DG013A as a tool compound inhibitor of the M1-aminopeptidase ERAP1., 42 [PMID:33887439] [10.1016/j.bmcl.2021.128050] |
Source(1):